APO Research

APO RESEARCH · REPORT

Artesunate Tablet

Artesunate (AS) is a medication used to treat malaria. The intravenous form is preferred to quinidine for severe malaria. Often it is used as part of combination therapy. It is not used for the prevention of malaria.

Product & engineering

Understand the product.

Artesunate (AS) is a medication used to treat malaria. The intravenous form is preferred to quinidine for severe malaria. Often it is used as part of combination therapy. It is not used for the prevention of malaria.

Selected research

Market Structure

Global Artesunate Tablet Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

Artesunate (AS) is a medication used to treat malaria. The intravenous form is preferred to quinidine for severe malaria. Often it is used as part of combination therapy. It is not used for the prevention of malaria.

Global Artesunate Tablet main players include Fosun Pharma (Guilin), Ipca Laboratories, Sanofi Aventis, Ajanta Pharma, Shin Poong, Cipla, Acino, MCW Healthcare, etc., totally accounting for about 70%. Central and South America is the largest market, with a share over 75%. As for the types of products, it can be divided into PA 90 Content, PA 95 Content and PA 98 Content. The most common product is Monoaromatic Artesunate and Compound Artesunate. In terms of applications, it is widely used in Hospital, Clinic and Others. The most application is in Hospital, with a share over 67%.

This report provides an overview of the global Artesunate Tablet market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Artesunate Tablet and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Artesunate Tablet sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Artesunate Tablet market size, projected growth trends, production technologies, key applications, and end-use industries.

Artesunate Tablet Segment by Company

Fosun Pharma (Guilin)

Ipca Laboratories

Sanofi Aventis

Ajanta Pharma

Shin Poong

Cipla

Acino

MCW Healthcare

Artesunate Tablet Segment by Type

Monoaromatic Artesunate

Compound Artesunate

Artesunate Tablet Segment by Application

Hospital

Clinic

Others

Artesunate Tablet Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artesunate Tablet market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Artesunate Tablet and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artesunate Tablet.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Artesunate Tablet market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Artesunate Tablet manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Artesunate Tablet in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Artesunate Tablet in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Artesunate Tablet Industry Trends Table 2. Artesunate Tablet Industry Drivers Table 3. Artesunate Tablet Industry Opportunities and Challenges Table 4. Artesunate Tablet Industry Restraints Table 5. Global Artesunate Tablet Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Artesunate Tablet Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Artesunate Tablet Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Artesunate Tablet Sales Market Share by Manufacturers Table 9. Global Artesunate Tablet Average Sales Price (USD/Unit) of Manufacturers (2021-2026) Table 10. Global Artesunate Tablet Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Artesunate Tablet Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Artesunate Tablet Manufacturers, Product Type & Application Table 13. Global Artesunate Tablet Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Artesunate Tablet by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Monoaromatic Artesunate Table 17. Major Manufacturers of Compound Artesunate Table 18. Global Artesunate Tablet Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Artesunate Tablet Sales by Type (2021-2026) & (K Units) Table 20. Global Artesunate Tablet Sales by Type (2027-2032) & (K Units) Table 21. Global Artesunate Tablet Sales Market Share by Type (2021-2026) Table 22. Global Artesunate Tablet Sales Market Share by Type (2027-2032) Table 23. Global Artesunate Tablet Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Artesunate Tablet Revenue by Type (2021-2026) & (K Units) Table 25. Global Artesunate Tablet Revenue by Type (2027-2032) & (K Units) Table 26. Global Artesunate Tablet Revenue Market Share by Type (2021-2026) Table 27. Global Artesunate Tablet Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Clinic Table 30. Major Manufacturers of Others Table 31. Global Artesunate Tablet Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Artesunate Tablet Sales by Application (2021-2026) & (K Units) Table 33. Global Artesunate Tablet Sales by Application (2027-2032) & (K Units) Table 34. Global Artesunate Tablet Sales Market Share by Application (2021-2026) Table 35. Global Artesunate Tablet Sales Market Share by Application (2027-2032) Table 36. Global Artesunate Tablet Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Artesunate Tablet Revenue by Application (2021-2026) & (K Units) Table 38. Global Artesunate Tablet Revenue by Application (2027-2032) & (K Units) Table 39. Global Artesunate Tablet Revenue Market Share by Application (2021-2026) Table 40. Global Artesunate Tablet Revenue Market Share by Application (2027-2032) Table 41. Global Artesunate Tablet Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Artesunate Tablet Sales by Region (2021-2026) & (K Units) Table 43. Global Artesunate Tablet Sales Market Share by Region (2021-2026) Table 44. Global Artesunate Tablet Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Artesunate Tablet Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Artesunate Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Artesunate Tablet Sales by Country (2021-2026) & (K Units) Table 48. North America Artesunate Tablet Sales by Country (2027-2032) & (K Units) Table 49. Europe Artesunate Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Artesunate Tablet Sales by Country (2021-2026) & (K Units) Table 51. Europe Artesunate Tablet Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Artesunate Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Artesunate Tablet Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Artesunate Tablet Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Artesunate Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Artesunate Tablet Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Artesunate Tablet Sales by Country (2027-2032) & (K Units) Table 58. Global Artesunate Tablet Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Artesunate Tablet Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Artesunate Tablet Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Artesunate Tablet Revenue Market Share by Region (2021-2026) Table 62. Global Artesunate Tablet Revenue Market Share by Region (2027-2032) Table 63. Fosun Pharma (Guilin) Company Information Table 64. Fosun Pharma (Guilin) Business Overview Table 65. Fosun Pharma (Guilin) Artesunate Tablet Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Fosun Pharma (Guilin) Artesunate Tablet Product Portfolio Table 67. Fosun Pharma (Guilin) Recent Development Table 68. Ipca Laboratories Company Information Table 69. Ipca Laboratories Business Overview Table 70. Ipca Laboratories Artesunate Tablet Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Ipca Laboratories Artesunate Tablet Product Portfolio Table 72. Ipca Laboratories Recent Development Table 73. Sanofi Aventis Company Information Table 74. Sanofi Aventis Business Overview Table 75. Sanofi Aventis Artesunate Tablet Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Sanofi Aventis Artesunate Tablet Product Portfolio Table 77. Sanofi Aventis Recent Development Table 78. Ajanta Pharma Company Information Table 79. Ajanta Pharma Business Overview Table 80. Ajanta Pharma Artesunate Tablet Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Ajanta Pharma Artesunate Tablet Product Portfolio Table 82. Ajanta Pharma Recent Development Table 83. Shin Poong Company Information Table 84. Shin Poong Business Overview Table 85. Shin Poong Artesunate Tablet Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Shin Poong Artesunate Tablet Product Portfolio Table 87. Shin Poong Recent Development Table 88. Cipla Company Information Table 89. Cipla Business Overview Table 90. Cipla Artesunate Tablet Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Cipla Artesunate Tablet Product Portfolio Table 92. Cipla Recent Development Table 93. Acino Company Information Table 94. Acino Business Overview Table 95. Acino Artesunate Tablet Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Acino Artesunate Tablet Product Portfolio Table 97. Acino Recent Development Table 98. MCW Healthcare Company Information Table 99. MCW Healthcare Business Overview Table 100. MCW Healthcare Artesunate Tablet Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. MCW Healthcare Artesunate Tablet Product Portfolio Table 102. MCW Healthcare Recent Development Table 103. Key Raw Materials Table 104. Raw Materials Key Suppliers Table 105. Artesunate Tablet Distributors List Table 106. Artesunate Tablet Customers List Table 107. Research Programs/Design for This Report Table 108. Authors List of This Report Table 109. Secondary Sources Table 110. Primary Sources List of Figures Figure 1. Artesunate Tablet Product Image Figure 2. Global Artesunate Tablet Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Artesunate Tablet Market Size (2021-2032) & (US$ Million) Figure 4. Global Artesunate Tablet Sales (2021-2032) & (K Units) Figure 5. Global Artesunate Tablet Average Price (USD/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Artesunate Tablet Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Monoaromatic Artesunate Image Figure 9. Compound Artesunate Image Figure 10. Global Artesunate Tablet Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Artesunate Tablet Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Artesunate Tablet Sales Market Share by Type (2021-2032) Figure 13. Global Artesunate Tablet Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Artesunate Tablet Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Artesunate Tablet Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Clinic Image Figure 18. Others Image Figure 19. Global Artesunate Tablet Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Artesunate Tablet Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Artesunate Tablet Sales Market Share by Application (2021-2032) Figure 22. Global Artesunate Tablet Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Artesunate Tablet Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Artesunate Tablet Revenue Market Share by Application (2021-2032) Figure 25. North America Artesunate Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Artesunate Tablet Sales Market Share by Country (2021-2032) Figure 27. U.S. Artesunate Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Artesunate Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Artesunate Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Artesunate Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Artesunate Tablet Sales Market Share by Country (2021-2032) Figure 32. Germany Artesunate Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Artesunate Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Artesunate Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Artesunate Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Artesunate Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Artesunate Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Artesunate Tablet Sales Market Share by Country (2021-2032) Figure 39. China Artesunate Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Artesunate Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Artesunate Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Artesunate Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Artesunate Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Artesunate Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Artesunate Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Artesunate Tablet Sales Market Share by Country (2021-2032) Figure 47. Brazil Artesunate Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Artesunate Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Artesunate Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Artesunate Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Artesunate Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Artesunate Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Artesunate Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Artesunate Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Artesunate Tablet Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Artesunate Tablet Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Artesunate Tablet Revenue (2021-2032) & (US$ Million) Figure 58. North America Artesunate Tablet Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Artesunate Tablet Revenue (2021-2032) & (US$ Million) Figure 60. Europe Artesunate Tablet Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Artesunate Tablet Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Artesunate Tablet Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Artesunate Tablet Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Artesunate Tablet Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Artesunate Tablet Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Artesunate Tablet Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Monoaromatic Artesunate
  • Compound Artesunate
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Fosun Pharma (Guilin)
  • Ipca Laboratories
  • Sanofi Aventis
  • Ajanta Pharma
  • Shin Poong
  • Cipla
  • Acino
  • MCW Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Artesunate Tablet Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Artesunate Tablet Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Artesunate Tablet Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Artesunate Tablet Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Artesunate Tablet Market Dynamics
  1. 2.1 Artesunate Tablet Industry Trends
  2. 2.2 Artesunate Tablet Industry Drivers
  3. 2.3 Artesunate Tablet Industry Opportunities and Challenges
  4. 2.4 Artesunate Tablet Industry Restraints
3 Artesunate Tablet Market by Manufacturers
  1. 3.1 Global Artesunate Tablet Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Artesunate Tablet Sales by Manufacturers (2021-2026)
  3. 3.3 Global Artesunate Tablet Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Artesunate Tablet Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Artesunate Tablet Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Artesunate Tablet Manufacturers, Product Type & Application
  7. 3.7 Global Artesunate Tablet Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Artesunate Tablet Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Artesunate Tablet Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Artesunate Tablet Tier 1, Tier 2, and Tier 3
4 Artesunate Tablet Market by Type
  1. 4.1 Artesunate Tablet Type Introduction
  2. 4.1.1 Monoaromatic Artesunate
  3. 4.1.2 Compound Artesunate
  4. 4.2 Global Artesunate Tablet Sales by Type
  5. 4.2.1 Global Artesunate Tablet Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Artesunate Tablet Sales by Type (2021-2032)
  7. 4.2.3 Global Artesunate Tablet Sales Market Share by Type (2021-2032)
  8. 4.3 Global Artesunate Tablet Revenue by Type
  9. 4.3.1 Global Artesunate Tablet Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Artesunate Tablet Revenue by Type (2021-2032)
  11. 4.3.3 Global Artesunate Tablet Revenue Market Share by Type (2021-2032)
5 Artesunate Tablet Market by Application
  1. 5.1 Artesunate Tablet Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Artesunate Tablet Sales by Application
  6. 5.2.1 Global Artesunate Tablet Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Artesunate Tablet Sales by Application (2021-2032)
  8. 5.2.3 Global Artesunate Tablet Sales Market Share by Application (2021-2032)
  9. 5.3 Global Artesunate Tablet Revenue by Application
  10. 5.3.1 Global Artesunate Tablet Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Artesunate Tablet Revenue by Application (2021-2032)
  12. 5.3.3 Global Artesunate Tablet Revenue Market Share by Application (2021-2032)
6 Global Artesunate Tablet Sales by Region
  1. 6.1 Global Artesunate Tablet Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Artesunate Tablet Sales by Region (2021-2032)
  3. 6.2.1 Global Artesunate Tablet Sales by Region (2021-2026)
  4. 6.2.2 Global Artesunate Tablet Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Artesunate Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Artesunate Tablet Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Artesunate Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Artesunate Tablet Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Artesunate Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Artesunate Tablet Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Artesunate Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Artesunate Tablet Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Artesunate Tablet Revenue by Region
  1. 7.1 Global Artesunate Tablet Revenue by Region
  2. 7.1.1 Global Artesunate Tablet Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Artesunate Tablet Revenue by Region (2021-2026)
  4. 7.1.3 Global Artesunate Tablet Revenue by Region (2027-2032)
  5. 7.1.4 Global Artesunate Tablet Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Artesunate Tablet Revenue (2021-2032)
  8. 7.2.2 North America Artesunate Tablet Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Artesunate Tablet Revenue (2021-2032)
  11. 7.3.2 Europe Artesunate Tablet Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Artesunate Tablet Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Artesunate Tablet Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Artesunate Tablet Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Artesunate Tablet Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Fosun Pharma (Guilin)
  2. 8.1.1 Fosun Pharma (Guilin) Company Information
  3. 8.1.2 Fosun Pharma (Guilin) Business Overview
  4. 8.1.3 Fosun Pharma (Guilin) Artesunate Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Fosun Pharma (Guilin) Artesunate Tablet Product Portfolio
  6. 8.1.5 Fosun Pharma (Guilin) Recent Developments
  7. 8.2 Ipca Laboratories
  8. 8.2.1 Ipca Laboratories Company Information
  9. 8.2.2 Ipca Laboratories Business Overview
  10. 8.2.3 Ipca Laboratories Artesunate Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Ipca Laboratories Artesunate Tablet Product Portfolio
  12. 8.2.5 Ipca Laboratories Recent Developments
  13. 8.3 Sanofi Aventis
  14. 8.3.1 Sanofi Aventis Company Information
  15. 8.3.2 Sanofi Aventis Business Overview
  16. 8.3.3 Sanofi Aventis Artesunate Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Sanofi Aventis Artesunate Tablet Product Portfolio
  18. 8.3.5 Sanofi Aventis Recent Developments
  19. 8.4 Ajanta Pharma
  20. 8.4.1 Ajanta Pharma Company Information
  21. 8.4.2 Ajanta Pharma Business Overview
  22. 8.4.3 Ajanta Pharma Artesunate Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Ajanta Pharma Artesunate Tablet Product Portfolio
  24. 8.4.5 Ajanta Pharma Recent Developments
  25. 8.5 Shin Poong
  26. 8.5.1 Shin Poong Company Information
  27. 8.5.2 Shin Poong Business Overview
  28. 8.5.3 Shin Poong Artesunate Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Shin Poong Artesunate Tablet Product Portfolio
  30. 8.5.5 Shin Poong Recent Developments
  31. 8.6 Cipla
  32. 8.6.1 Cipla Company Information
  33. 8.6.2 Cipla Business Overview
  34. 8.6.3 Cipla Artesunate Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Cipla Artesunate Tablet Product Portfolio
  36. 8.6.5 Cipla Recent Developments
  37. 8.7 Acino
  38. 8.7.1 Acino Company Information
  39. 8.7.2 Acino Business Overview
  40. 8.7.3 Acino Artesunate Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Acino Artesunate Tablet Product Portfolio
  42. 8.7.5 Acino Recent Developments
  43. 8.8 MCW Healthcare
  44. 8.8.1 MCW Healthcare Company Information
  45. 8.8.2 MCW Healthcare Business Overview
  46. 8.8.3 MCW Healthcare Artesunate Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 MCW Healthcare Artesunate Tablet Product Portfolio
  48. 8.8.5 MCW Healthcare Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Artesunate Tablet Value Chain Analysis
  2. 9.1.1 Artesunate Tablet Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Artesunate Tablet Production Mode & Process
  6. 9.2 Artesunate Tablet Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Artesunate Tablet Distributors
  9. 9.2.3 Artesunate Tablet Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research